$IOVA news
The latest IOVA stock news: headlines, filings, AI summaries and sentiment for $IOVA, updated around the clock.
- Pomerantz Law Firm Investigates Iovance Biotherapeutics Following Clinical Trial Data Discrepancy
- IOVANCE BIOTHERAPEUTICS, INC. - 8-K Filing
- Iovance Biotherapeutics Reports Q3 2026 Record Revenue Driven by AMTAGVI Growth
- IOVANCE BIOTHERAPEUTICS, INC. - 10-Q Filing
- Iovance Biotherapeutics Reports Q3 Revenue Growth of 80% and EPS Beat
- IOVANCE BIOTHERAPEUTICS, INC. - 8-K Filing
- IOVANCE BIOTHERAPEUTICS, INC. - 8-K Filing
- Iovance Biotherapeutics Shares Drop 34% Following Phase 2 Amtagvi Data for Lung Cancer
- IOVANCE BIOTHERAPEUTICS, INC. - 8-K Filing
- Goldman Sachs Resumes Coverage of Iovance Biotherapeutics with Buy Rating
- Iovance Biotherapeutics Updates Corporate Presentation with Key Financials and Pipeline Progress
- Iovance (IOVA) Reports Q1 2026 Earnings with Strong Revenue Growth
- Obsidian Therapeutics to Begin Trading on Nasdaq After Reverse Merger with Galera Therapeutics